Parkinson’s disease managing reversible neurodegeneration

This paper has been retracted.Marty Hinz, 1 Alvin Stein, 2 Ted Cole, 3 Beth McDougall, 4 Mark Westaway 5 1Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, 2Stein Orthopedic Associates, Plantation, FL, 3Cole Center for Healing, Cincinnati, OH, 4CLEARCenter of Health, Mill Valley, CA,...

Full description

Saved in:
Bibliographic Details
Main Authors: Hinz M, Stein A, Cole T, McDougall B, Westaway M
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Online Access:https://www.dovepress.com/parkinsonrsquos-disease-managing-reversible-neurodegeneration-peer-reviewed-fulltext-article-NDT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849424635958919168
author Hinz M
Stein A
Cole T
McDougall B
Westaway M
author_facet Hinz M
Stein A
Cole T
McDougall B
Westaway M
author_sort Hinz M
collection DOAJ
description This paper has been retracted.Marty Hinz, 1 Alvin Stein, 2 Ted Cole, 3 Beth McDougall, 4 Mark Westaway 5 1Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, 2Stein Orthopedic Associates, Plantation, FL, 3Cole Center for Healing, Cincinnati, OH, 4CLEARCenter of Health, Mill Valley, CA, USA; 5Four Pillars Health, Brendale, QLD, Australia Abstract: Traditionally, the Parkinson’s disease (PD) symptom course has been classified as an irreversible progressive neurodegenerative disease. This paper documents 29 PD and treatment-induced systemic depletion etiologies which cause and/or exacerbate the seven novel primary relative nutritional deficiencies associated with PD. These reversible relative nutritional deficiencies (RNDs) may facilitate and accelerate irreversible progressive neurodegeneration, while other reversible RNDs may induce previously undocumented reversible pseudo-neurodegeneration that is hiding in plain sight since the symptoms are identical to the symptoms being experienced by the PD patient. Documented herein is a novel nutritional approach for reversible processes management which may slow or halt irreversible progressive neurodegenerative disease and correct reversible RNDs whose symptoms are identical to the patient’s PD symptoms. Keywords: Parkinson’s disease, L-dopa, carbidopa, B6, neurodegenerationCorrigendum for this paper has been publishedExpression of Concern for this paper has been published
format Article
id doaj-art-d4f292d315b64b16a718ebc901c42e11
institution Kabale University
issn 1178-2021
language English
publishDate 2016-04-01
publisher Dove Medical Press
record_format Article
series Neuropsychiatric Disease and Treatment
spelling doaj-art-d4f292d315b64b16a718ebc901c42e112025-08-20T03:30:04ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212016-04-01Volume 12Issue 176377526312Parkinson’s disease managing reversible neurodegenerationHinz M0Stein ACole TMcDougall B1Westaway MDepartment of Clinical ResearchInternal medicineThis paper has been retracted.Marty Hinz, 1 Alvin Stein, 2 Ted Cole, 3 Beth McDougall, 4 Mark Westaway 5 1Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, 2Stein Orthopedic Associates, Plantation, FL, 3Cole Center for Healing, Cincinnati, OH, 4CLEARCenter of Health, Mill Valley, CA, USA; 5Four Pillars Health, Brendale, QLD, Australia Abstract: Traditionally, the Parkinson’s disease (PD) symptom course has been classified as an irreversible progressive neurodegenerative disease. This paper documents 29 PD and treatment-induced systemic depletion etiologies which cause and/or exacerbate the seven novel primary relative nutritional deficiencies associated with PD. These reversible relative nutritional deficiencies (RNDs) may facilitate and accelerate irreversible progressive neurodegeneration, while other reversible RNDs may induce previously undocumented reversible pseudo-neurodegeneration that is hiding in plain sight since the symptoms are identical to the symptoms being experienced by the PD patient. Documented herein is a novel nutritional approach for reversible processes management which may slow or halt irreversible progressive neurodegenerative disease and correct reversible RNDs whose symptoms are identical to the patient’s PD symptoms. Keywords: Parkinson’s disease, L-dopa, carbidopa, B6, neurodegenerationCorrigendum for this paper has been publishedExpression of Concern for this paper has been publishedhttps://www.dovepress.com/parkinsonrsquos-disease-managing-reversible-neurodegeneration-peer-reviewed-fulltext-article-NDTParkinson’s diseaseL-dopacarbidopaB6neurodegeneration
spellingShingle Hinz M
Stein A
Cole T
McDougall B
Westaway M
Parkinson’s disease managing reversible neurodegeneration
Neuropsychiatric Disease and Treatment
Parkinson’s disease
L-dopa
carbidopa
B6
neurodegeneration
title Parkinson’s disease managing reversible neurodegeneration
title_full Parkinson’s disease managing reversible neurodegeneration
title_fullStr Parkinson’s disease managing reversible neurodegeneration
title_full_unstemmed Parkinson’s disease managing reversible neurodegeneration
title_short Parkinson’s disease managing reversible neurodegeneration
title_sort parkinson amp rsquo s disease managing reversible neurodegeneration
topic Parkinson’s disease
L-dopa
carbidopa
B6
neurodegeneration
url https://www.dovepress.com/parkinsonrsquos-disease-managing-reversible-neurodegeneration-peer-reviewed-fulltext-article-NDT
work_keys_str_mv AT hinzm parkinsonamprsquosdiseasemanagingreversibleneurodegeneration
AT steina parkinsonamprsquosdiseasemanagingreversibleneurodegeneration
AT colet parkinsonamprsquosdiseasemanagingreversibleneurodegeneration
AT mcdougallb parkinsonamprsquosdiseasemanagingreversibleneurodegeneration
AT westawaym parkinsonamprsquosdiseasemanagingreversibleneurodegeneration